Expect 76 or more super responder from the Anavex Phase 2b/3 early Alzheimer’s trial. Remember a super responder actually improves over time better than when they started taking Blarcamesine. For super responders blarcamesine doesn’t just slow the progression of Alzheimer’s disease it actually reverses the disease.
For the OLE extension expect 230 or more super responders.
Market Data 
Markets 
AI
